NO180483C - Forbindelse som tilhörer familien av 15-deoksyspergualinanaloger, terapeutisk preparat inneholdende denne, anvendelse derav og mellomprodukt for syntese av forbindelsen - Google Patents

Forbindelse som tilhörer familien av 15-deoksyspergualinanaloger, terapeutisk preparat inneholdende denne, anvendelse derav og mellomprodukt for syntese av forbindelsen

Info

Publication number
NO180483C
NO180483C NO934338A NO934338A NO180483C NO 180483 C NO180483 C NO 180483C NO 934338 A NO934338 A NO 934338A NO 934338 A NO934338 A NO 934338A NO 180483 C NO180483 C NO 180483C
Authority
NO
Norway
Prior art keywords
compound
deoxypergualin
analogs
family
synthesis
Prior art date
Application number
NO934338A
Other languages
English (en)
Norwegian (no)
Other versions
NO934338L (no
NO180483B (no
NO934338D0 (no
Inventor
Patrice Renaut
Luc Lebreton
Patrick Dutartre
Philippe Derrepas
Soth Samreth
Original Assignee
Fournier Ind & Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Ind & Sante filed Critical Fournier Ind & Sante
Publication of NO934338D0 publication Critical patent/NO934338D0/no
Publication of NO934338L publication Critical patent/NO934338L/no
Publication of NO180483B publication Critical patent/NO180483B/no
Publication of NO180483C publication Critical patent/NO180483C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Soil Conditioners And Soil-Stabilizing Materials (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO934338A 1992-12-02 1993-11-30 Forbindelse som tilhörer familien av 15-deoksyspergualinanaloger, terapeutisk preparat inneholdende denne, anvendelse derav og mellomprodukt for syntese av forbindelsen NO180483C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9214517A FR2698628B1 (fr) 1992-12-02 1992-12-02 Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.

Publications (4)

Publication Number Publication Date
NO934338D0 NO934338D0 (no) 1993-11-30
NO934338L NO934338L (no) 1994-06-03
NO180483B NO180483B (no) 1997-01-20
NO180483C true NO180483C (no) 1997-04-30

Family

ID=9436147

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934338A NO180483C (no) 1992-12-02 1993-11-30 Forbindelse som tilhörer familien av 15-deoksyspergualinanaloger, terapeutisk preparat inneholdende denne, anvendelse derav og mellomprodukt for syntese av forbindelsen

Country Status (24)

Country Link
US (1) US5476870A (zh)
EP (1) EP0600762B1 (zh)
JP (1) JP2945261B2 (zh)
KR (1) KR100187328B1 (zh)
CN (1) CN1045431C (zh)
AT (1) ATE140215T1 (zh)
AU (1) AU664124B2 (zh)
CA (1) CA2110437C (zh)
CZ (1) CZ284958B6 (zh)
DE (1) DE69303583T2 (zh)
DK (1) DK0600762T3 (zh)
ES (1) ES2092263T3 (zh)
FI (1) FI112211B (zh)
FR (1) FR2698628B1 (zh)
GR (1) GR3021269T3 (zh)
HK (1) HK1000467A1 (zh)
HU (1) HU218908B (zh)
NO (1) NO180483C (zh)
NZ (1) NZ250330A (zh)
RU (1) RU2114823C1 (zh)
SK (1) SK280286B6 (zh)
TW (1) TW311132B (zh)
UA (1) UA39920C2 (zh)
ZA (1) ZA938821B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2187281A1 (en) * 1995-02-10 1996-08-15 Luc Lebreton 15-deoxyspergualin analogs, their use in therapeutics and their method of preparation
FR2734263B1 (fr) * 1995-05-17 1997-06-20 Fournier Ind & Sante Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique
DE19728436A1 (de) * 1997-07-03 1999-01-07 Niels Franke Niedrigdosierte 15-Desoxyspergualin-Präparate
EP1107998B1 (en) * 1998-08-28 2004-02-04 Gryphon Sciences Method for the preparation of polyamide chains of precise length, their conjugates with proteins
DE19923961A1 (de) * 1999-05-25 2000-11-30 Euro Nippon Kayaku Gmbh Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen
JP5166022B2 (ja) * 2004-05-05 2013-03-21 サイレンス・セラピューティクス・アーゲー 脂質、脂質複合体、およびその使用
KR101366482B1 (ko) 2004-12-27 2014-02-21 사일런스 테라퓨틱스 아게 코팅된 지질 복합체 및 이들의 용도
WO2010074591A1 (ru) 2008-12-24 2010-07-01 Закрытое Акционерное Общество "Beptekc" Амиды креатина, способ их получения, средство, обладающее нейропротекторным действием
RU2428414C2 (ru) 2009-11-03 2011-09-10 Закрытое Акционерное Общество "Вертекс" Способ получения амидов креатина
JP5878172B2 (ja) * 2010-07-29 2016-03-08 ラボラトワール フルニエ エスアーエス 炎症性眼疾患の治療/予防用化合物
FR2963238B1 (fr) * 2010-07-29 2012-12-28 Fournier Lab Sa Derives de 15-desoxyspergualine pour le traitement et/ou la prevention des maladies inflammatoires oculaires
KR101695730B1 (ko) 2015-03-10 2017-01-12 하경훈 마늘꼭지 절단기의 절단장치
FR3050455B1 (fr) * 2016-04-26 2019-06-14 Temisis Derives amides des acides polycafeoylquiniques, procede de preparation et utilisations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5942356A (ja) * 1982-09-02 1984-03-08 Microbial Chem Res Found スパガリン関連化合物およびその製造法
ES2039213T3 (es) * 1986-04-04 1993-09-16 Microbial Chemistry Research Foundation Procedimiento para producir nuevos compuestos relacionados con espergualina.
US5061787A (en) * 1988-06-24 1991-10-29 Nippon Kayaku Kabushiki Kaisha Novel spergualin-related compounds and compositions

Also Published As

Publication number Publication date
FI935318A (fi) 1994-06-03
CN1045431C (zh) 1999-10-06
FR2698628A1 (fr) 1994-06-03
FI935318A0 (fi) 1993-11-29
EP0600762A1 (fr) 1994-06-08
CA2110437A1 (en) 1994-06-03
ES2092263T3 (es) 1996-11-16
ZA938821B (en) 1994-06-30
TW311132B (zh) 1997-07-21
DE69303583D1 (de) 1996-08-14
HU9303406D0 (en) 1994-03-28
CZ284958B6 (cs) 1999-04-14
GR3021269T3 (en) 1997-01-31
AU5188393A (en) 1994-06-16
NO934338L (no) 1994-06-03
CN1095709A (zh) 1994-11-30
AU664124B2 (en) 1995-11-02
SK280286B6 (sk) 1999-11-08
HUT65782A (en) 1994-07-28
DE69303583T2 (de) 1996-11-21
JPH06293728A (ja) 1994-10-21
ATE140215T1 (de) 1996-07-15
US5476870A (en) 1995-12-19
CA2110437C (en) 1999-04-13
FR2698628B1 (fr) 1995-02-17
FI112211B (fi) 2003-11-14
RU2114823C1 (ru) 1998-07-10
EP0600762B1 (fr) 1996-07-10
KR940014435A (ko) 1994-07-18
CZ262293A3 (en) 1994-06-15
SK135793A3 (en) 1994-06-08
HK1000467A1 (en) 1998-03-27
KR100187328B1 (ko) 1999-05-15
HU218908B (hu) 2000-12-28
NO180483B (no) 1997-01-20
UA39920C2 (uk) 2001-07-16
JP2945261B2 (ja) 1999-09-06
NZ250330A (en) 1995-06-27
NO934338D0 (no) 1993-11-30
DK0600762T3 (da) 1996-11-11

Similar Documents

Publication Publication Date Title
DK0580502T3 (da) 3-(hydroxybenzylidenyl)-indolin-2-oner og farmaceutiske sammensætninger indeholdende disse
NO180483C (no) Forbindelse som tilhörer familien av 15-deoksyspergualinanaloger, terapeutisk preparat inneholdende denne, anvendelse derav og mellomprodukt for syntese av forbindelsen
DK0513543T3 (da) Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og antikoagulationsmidler med indehold deraf
NO301419B1 (no) 2-okso-5-oksazolidinmetylforbindelser, farmasöytiske preparater som inneholder slike, og anvendelse derav for fremstilling av legemidler
DK0534859T3 (da) 3-Benzazepin-2-oner, som er substituerede med en benzocyklobutyl- eller indanylalkylaminoalkylgruppe, og som er anvendelige til behandling af cardiovaskulære sygdomme
SE9002206D0 (sv) New compounds
DK0618209T3 (da) Pyridothiadiaziner, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem
IL113011A (en) R-mandelic acid salt of (2s,3s)-3- (2-methoxybenzylamino)-2- phenylpiperidine
DE69202166D1 (de) Verwendung von Tetrahydrothienopyridinderivate als Angiogenese-Inhibitoren.
NZ218773A (en) 3-methyl-2-oxo-1-(substituted phenyl)-naphthyridines and pharmaceutical compositions
GR3015512T3 (en) Thiophene derivatives, process for their preparation and pharmaceutical compositions containing them.
GR3002558T3 (en) Synergistinic derivatives, their preparation and pharmaceutical compositions containing them
HUP0301010A2 (hu) A koleszteril-észter és a viaszészter szintézisét egyaránt gátló vegyületek faggyúmirigy-betegségek kezeléséhez és ezeket tartalmazó gyógyszerkészítmények
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
ZA896617B (en) Sulphonamides,processes for their preparation and pharmaceutical compositions
FI924769A (fi) Foerfarande foer framstaellning av substituerade indoler
ATE110739T1 (de) Tuftsin-analoge und impfstoffe, die diese analoge als adjuvantien enthalten.
JO1672B1 (en) Dialoxy-pyridinyl-benzimidazole derivatives and a way to prepare and use it in a pharmacy
JO1674B1 (en) Benzimidazole is an alternative and method of preparation and use of a pharmacist

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees